Real-world Evidence

• 19th Oct 2026

  Review of: “Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid”

• 15th Apr 2026

  Review of: Innovative Contracting for Gene Therapies: Current Landscape and Perspectives on the Future of Gene Therapy Financing in the USA

• 9th Feb 2026

  Review of: “Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum”